Equity Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Acquisitions, Joint Ventures and New...
November 08 2011 - 8:00AM
Marketwired
www.stockcall.com/ offers investors comprehensive research on the
Drug Manufacturers - Other industry and has completed analytical
research on
Teva Pharmaceutical Industries
Limited (NASDAQ: TEVA) and
Forest
Laboratories Inc. (NYSE: FRX). Register with us today at
www.stockcall.com/ to have free access to these researches.
The Drug Manufacturers - Other industry has been a hive of
activity recently, with patent expiries, company takeovers and new
products all factoring into the industry outlook. Companies such as
Teva Pharmaceuticals Industries Ltd. have been busy of late with
foreign expansions and domestic partnerships. Teva and Proctor
& Gamble Co. have announced the particulars of their new joint
venture which will be involved in bringing branded generic products
to market. Teva Pharmaceutical Industries
Limited research report is accessible for free by registering
today at www.stockcall.com/TEVA081111.pdf.
www.stockcall.com/ is an online platform where investors doing
their due-diligence on the Drug Manufacturers - Other industry can
have easy and free access to our analyst research and opinions on
Teva Pharmaceutical Industries Limited and Forest Laboratories
Inc.; investors and shareholders of these companies can simply
register for a complimentary membership at
https://stockcall.com/development/stockcall/page.php?name=register.html.
While new markets and joint ventures can benefit companies, the
industry relies heavily on research and development. Many new
products have recently been announced by a plethora of companies in
the industry, including Forest Laboratories Inc. The company,
together with Ironwood Pharmaceuticals Inc., has recently stated
that their new drug application, involving the treatment of
irritable bowel syndrome, has been accepted for FDA review.
Forest Laboratories Inc. research report is
available for free by signing up now at
www.stockcall.com/FRX081111.pdf.
As companies in the Drug Manufacturers - Other industry continue
to make headlines it will be interesting to see which development
strategy works best when year-end reports are released. Register
now at
https://stockcall.com/development/stockcall/page.php?name=register.html
to have free access to our reports on the Drug Manufacturers -
Other industry.
About StockCall.com StockCall.com is a
financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the
headlines.
Contact Person: William T. Knight
stockcall2010@gmail.com
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024